Acute liver failure is not simply a very high aminotransferase result. In the adult syndrome, acute hepatic dysfunction is linked to impaired coagulation and hepatic encephalopathy, usually without established chronic liver disease, although recognised exceptions exist. The FFICM task is to identify evolving organ failure, investigate the cause and involve specialist liver services early enough for the trajectory to matter.
This article uses a fictional adult case prepared in September 2026. The clinical framework was checked on 27 September 2026 against the EASL acute liver failure guideline and the 2024 practical update in JHEP Reports. It is not a transplant-listing protocol or a paediatric liver-failure guide.
Define the syndrome and establish the timeline
Ask when the patient was last well, when symptoms and jaundice began, and when mental-state changes appeared. Establish previous liver disease, relevant investigations and the reliability of the available history. Acute-on-chronic liver failure is a related but distinct clinical framework, not a synonym for acute liver failure.
The EASL definition is deliberately more specific than "abnormal liver tests". A person with acute liver injury but no encephalopathy still requires appropriate assessment and may deteriorate; failure to meet the full syndrome definition is not reassurance that referral can wait.
Mental-state assessment also requires care. Confusion may have several causes, including hypoglycaemia, medicines, infection and other neurological processes. Describe the observation and investigate contributors rather than attributing every change automatically to hepatic encephalopathy.
Build a cause-directed investigation
Take a precise exposure history, including prescribed medicines, over-the-counter preparations, supplements and possible toxins. Record timing, uncertainty and corroborating information without assuming that a negative initial account excludes an exposure. Consider infectious, autoimmune, vascular, pregnancy-related and other causes according to the patient and presentation.
The investigation should answer the cause question while supporting urgent care. Waiting for every aetiological result before discussing a deteriorating patient with a specialist service can lose time. Conversely, an early suspected cause does not justify ignoring competing explanations or new evidence.
The 2024 practical update discusses the parallel need for aetiological investigation, organ support and specialist assessment. It also reinforces that management of encephalopathy in acute liver failure should not be copied uncritically from a chronic-cirrhosis pathway.
Read laboratory trends as different kinds of information
Aminotransferases indicate hepatocellular injury; they are not a direct measure of all liver functions or recovery. Coagulation results, glucose, lactate, renal function and the clinical examination add different information. Their timing and the treatments already given affect interpretation.
A falling aminotransferase result can accompany improvement, but it can also occur in a patient whose overall condition is worsening. Do not treat the direction of that one number as the outcome. The relevant question is whether synthetic function, metabolic stability, consciousness and other organ systems are recovering.
Coagulation abnormalities also require context. An abnormal INR is not itself a complete measure of bleeding risk or an automatic instruction to normalise the result with blood products. The EASL guidance distinguishes monitoring and prognosis from treatment decisions, which depend on bleeding, procedures and the full clinical situation.
Follow an evolving fictional laboratory table
All values below are invented teaching data. The table does not represent a treatment threshold or the performance of a prognostic score.
| Observation | First assessment | Subsequent assessment | Interpretation question |
|---|---|---|---|
| ALT, U/L | 3,200 | 1,800 | Does the falling injury marker agree with the rest of the trajectory? |
| INR | 2.2 | 3.5 | Is synthetic dysfunction worsening, and what treatment or sampling context matters? |
| Glucose, mmol/L | 4.1 | 3.0 | Does this require immediate correction and closer metabolic surveillance? |
| Lactate, mmol/L | 2.8 | 4.6 | What do perfusion, clearance and the clinical course suggest? |
| Mental state | Conversational but slowed | More drowsy and difficult to assess | Is the airway or neurological risk changing? |
The correct interpretation is not "ALT has improved, continue the same plan". Several other observations are concerning. The low glucose requires prompt clinical attention, while the altered consciousness and wider deterioration strengthen the need for critical-care and specialist liver input.
The exercise intentionally leaves the cause unresolved. A numerical pattern can establish concern without proving aetiology. State what you know, what is suspected and what must happen before the remaining uncertainty is resolved.
Connect encephalopathy with support priorities
Assess airway protection, ventilation, circulation and neurological state, while considering reversible contributors to impaired consciousness. Severe deterioration may require advanced organ support, but the decision depends on actual assessment and appropriate expertise rather than a label in a revision table.
The 2024 review describes the particular cerebral and metabolic risks of acute liver failure. A general ICU approach remains necessary, but it must be adapted to the liver-failure context. Sedation and other interventions can also alter subsequent neurological assessment, so document their timing and purpose.
Use a two-track mental model:
Support the patient now: airway, circulation, glucose and organ dysfunction
Investigate and treat the cause: exposure, infection, immune or vascular context
Both tracks feed into early specialist assessment and repeated review.
The diagram is an original organising aid, not a sequential protocol. One track must not wait until the other has been completed.
Make the specialist referral useful
A referral should include the onset and course of illness, prior liver context, suspected cause, consciousness, current support, serial laboratory findings and the treatments already given. State whether the patient is deteriorating and what local capabilities or transfer constraints matter.
For the fictional patient: "An adult without known established cirrhosis has acute hepatic injury with worsening coagulation, new hypoglycaemia and increasing drowsiness. ALT has fallen, but the overall trajectory is worse. We are addressing immediate physiological problems and need urgent liver-service advice on further management and transfer."
That is more useful than reporting only the highest ALT. The EASL guideline and subsequent practical update support early specialised management; a prognostic or listing criterion should not be misused as a requirement to delay discussion until the patient becomes sicker.
Compare plausible but incomplete answers
"Give the standard cirrhosis encephalopathy treatment" imports a pathway without establishing applicability. "Correct the INR to normal" treats a monitoring variable as a universal therapeutic target. "Wait for the toxicology result" postpones support and referral despite deterioration. "The ALT is lower, so the liver is recovering" mistakes an injury marker for the whole syndrome.
A stronger answer integrates the timeline, differentiates support from cause-specific treatment and makes uncertainty visible. It also states how the plan will be reviewed: repeated consciousness assessment, glucose and other laboratory trends, circulatory status, renal function and the specialist service's advice.
For revision, present the table one column at a time. Ask a partner to identify the single finding that most changes the immediate priority, then require an explanation of why the remaining findings still matter. Per iatroX product information for September 2026, the Tutor can explore that reasoning after an attempted question; it does not establish transplant eligibility or replace specialist care.
Frequently asked questions
Does a falling ALT prove recovery from acute liver failure?
No. Interpret it alongside consciousness, coagulation, glucose, lactate, renal function and the overall clinical trajectory.
Is acute liver failure the same as decompensated cirrhosis?
No. The syndromes have different definitions and management considerations, so the chronic-disease context must be established.
Should referral wait until a transplant-listing criterion is met?
No. Specialist discussion and transfer planning may be needed earlier, according to the patient's condition and current liver-service guidance.